Literature DB >> 6158375

Augmentation of human monocyte-mediated cytolysis by interferon.

J R Jett, A Mantovani, R B Herberman.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6158375     DOI: 10.1016/0008-8749(80)90222-1

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


× No keyword cloud information.
  21 in total

1.  Synthesis of gelatin microspheres containing interferon.

Authors:  Y Tabata; Y Ikada
Journal:  Pharm Res       Date:  1989-05       Impact factor: 4.200

2.  Enhancement of defective monocyte function during immunotherapy with recombinant interferon.

Authors:  H Nielsen; P Ernst
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

3.  Augmentation of natural and antibody-dependent cell-mediated cytotoxicity by pure human leukocyte interferon.

Authors:  R B Herberman; J R Ortaldo; M Rubinstein; S Pestka
Journal:  J Clin Immunol       Date:  1981-07       Impact factor: 8.317

4.  Combined activation of murine lymphocytes with staphylococcal enterotoxin and interleukin-2 results in additive cytotoxic activity.

Authors:  H Belfrage; P Bhiladvala; G Hedlund; M Dohlsten; T Kalland
Journal:  Cancer Immunol Immunother       Date:  1994-04       Impact factor: 6.968

5.  Effect of colony stimulating factor on murine macrophages. Induction of antitumor activity.

Authors:  E J Wing; A Waheed; R K Shadduck; L S Nagle; K Stephenson
Journal:  J Clin Invest       Date:  1982-02       Impact factor: 14.808

6.  Antibody-dependent and -independent cytotoxicity of human mononuclear phagocytes: defective stimulation of tumoricidal activity in milk macrophages.

Authors:  A Biondi; G Peri; N Colombo; G Bolis; A Mantovani
Journal:  Clin Exp Immunol       Date:  1982-09       Impact factor: 4.330

7.  Direct and indirect effects of human interferon alpha on renal cell carcinoma: a new in vitro assay system for evaluating cytokine-mediated antitumor effects.

Authors:  H Matsuyama; S Yoshihiro; Y Ohmoto; N Yamamoto; K Naito
Journal:  Cancer Immunol Immunother       Date:  1993-07       Impact factor: 6.968

8.  Defective interleukin-1 production by monocytes from patients with malignant disease. Interferon increases IL-1 production.

Authors:  J Herman; M C Kew; A R Rabson
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

9.  Antitumor activity of living or killed Brucella: modification of the non-specific cytotoxic effector cells.

Authors:  L Dazord; Y le Garrec; I Florentin
Journal:  Cancer Immunol Immunother       Date:  1983       Impact factor: 6.968

Review 10.  The interferons.

Authors:  J L Toy
Journal:  Clin Exp Immunol       Date:  1983-10       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.